Intrinsic Value of S&P & Nasdaq Contact Us

Cyclo Therapeutics, Inc. CYTH NASDAQ

NASDAQ Capital Marke • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
46/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$0.95
+31.8%

Cyclo Therapeutics, Inc. (CYTH) has 19 known insider and institutional holders on record. The largest holder is ARMISTICE CAPITAL, LLC with 15,801,269 shares. Other notable holders include Rafael Holdings, Inc. and NOVIT, L.P..

CYTH Insider Ownership

Top Holder
ARMISTICE CAPITAL, LLC
15,801,269 shares
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Armistice Capital, Llc 10 Percent Owner 15,801,269 2020-10-01
100%
2 Rafael Holdings, Inc. 10 Percent Owner 12,998,194 2025-01-13
82%
3 Novit, L.p. 10 Percent Owner 10,000,000 2020-09-02
63%
4 Fails George L Director 1,685,221 2017-04-04
11%
5 Sieger Markus Director 440,260 2025-03-03
3%
6 Ostronic Francis Patrick Director 419,100 2025-03-03
3%
7 Strattan Ce Rick Director 399,272 2025-03-03
3%
8 Fine N Scott Chief Executive Officer 266,354 2024-06-05
2%
9 Toig Randall M. Director 179,137 2025-03-03
1%
10 Shanahan William S Director 173,966 2025-02-28
1%
11 Cross Shawn Director 136,346 2025-03-03
1%
12 Fine Joshua M Chief Financial Officer 110,732 2024-06-05
1%
13 Lisjak Michael Eric Chief Regulatory Officer 110,732 2024-06-05
1%
14 Tate Jeffrey Chief Operating Officer 110,732 2024-06-05
1%
15 Conkling William Director 77,884 2025-03-03
0%
16 Wong Vivien Director 64,853 2025-03-03
0%
17 Kjems Lise Lund Chief Medical Officer 55,453 2023-03-10
0%
18 Hrynkow Sharon Hemond Chief Scientific Officer 19,350 2021-12-02
0%
19 Farnan Joseph J Jr Director 10,000 2019-01-02
0%

No ownership data available for CYTH.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message